{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T11:35:12Z","timestamp":1767180912680,"version":"build-2238731810"},"reference-count":77,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2013,2,20]],"date-time":"2013-02-20T00:00:00Z","timestamp":1361318400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0056704","type":"journal-article","created":{"date-parts":[[2013,2,20]],"date-time":"2013-02-20T17:56:05Z","timestamp":1361382965000},"page":"e56704","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Parallel Screening of Wild-Type and Drug-Resistant Targets for Anti-Resistance Neuraminidase Inhibitors"],"prefix":"10.1371","volume":"8","author":[{"given":"Kai-Cheng","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Chen","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim-Tong","family":"Horng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Yu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Yu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Jung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Chu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding-Li","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Wei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsing-Pang","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinn-Moon","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John T.-A.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,2,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1126\/science.275.5301.756","article-title":"Medicine - Researchers seek new weapon against the flu","volume":"275","year":"1997","journal-title":"Science"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1126\/science.270.5244.1916","article-title":"Infectious-Disease - Planning for the Next Flu Pandemic","volume":"270","author":"E Pennisi","year":"1995","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nature08157","article-title":"Emergence and pandemic potential of swine-origin H1N1 influenza virus","volume":"459","author":"G Neumann","year":"2009","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"RRN1003","DOI":"10.1371\/currents.RRN1003","article-title":"The early molecular epidemiology of the swine-origin A\/H1N1 human influenza pandemic","volume":"1","author":"A Rambaut","year":"2009","journal-title":"PLoS Currents"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0378-1119(97)00322-3","article-title":"The human RAE1 gene is a functional homologue of Schizosaccharomyces pombe rae1 gene involved in nuclear export of Poly(A)(+) RNA","volume":"198","author":"A Bharathi","year":"1997","journal-title":"Gene"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.2174\/138161207782794248","article-title":"Strategies of development of antiviral agents directed against influenza virus replication","volume":"13","author":"HP Hsieh","year":"2007","journal-title":"Current Pharmaceutical Design"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/0042-6822(74)90458-9","article-title":"Inhibition of influenza and parainfluenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA)","volume":"59","author":"P Palese","year":"1974","journal-title":"Virology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0042-6822(66)90178-4","article-title":"Functional significance of sialidose during influenza virus multiplication","volume":"30","author":"JT Seto","year":"1966","journal-title":"Virology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/363418a0","article-title":"Rational design of potent sialidase-based inhibitors of influenza virus replication","volume":"363","author":"M von Itzstein","year":"1993","journal-title":"Nature"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1128\/AAC.42.3.647","article-title":"Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071","volume":"42","author":"WX Li","year":"1998","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1021\/jm0002679","article-title":"BCX-1812 (RWJ-270201): Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design","volume":"43","author":"YS Babu","year":"2000","journal-title":"Journal of Medicinal Chemistry"},{"key":"ref12","first-page":"93","article-title":"Antiviral drugs for prophylaxis and treatment of influenza","volume":"47","journal-title":"Medical Letter on Drugs and Therapeutics"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa054512","article-title":"Oseltamivir resistance during treatment of influenza A (H5N1) infection","volume":"353","author":"MD de Jong","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0166-3542(01)00215-7","article-title":"Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo","volume":"54","author":"J Carr","year":"2002","journal-title":"Antiviral Research"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1086\/656439","article-title":"Recovery of a Multidrug-Resistant Strain of Pandemic Influenza A 2009 (H1N1) Virus Carrying a Dual H275Y\/I223R Mutation from a Child after Prolonged Treatment with Oseltamivir","volume":"51","author":"HT Nguyen","year":"2010","journal-title":"Clinical Infectious Diseases"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/AAC.00334-09","article-title":"In vitro generation of neuraminidase inhibitor resistance in A(H5N1) influenza viruses","volume":"53","author":"AC Hurt","year":"2009","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1021\/jm901386e","article-title":"Discovery of Novel Fibroblast Growth Factor Receptor 1 Kinase Inhibitors by Structure-Based Virtual Screening","volume":"53","author":"KP Ravindranathan","year":"2010","journal-title":"Journal of Medicinal Chemistry"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1016\/j.bmcl.2009.10.036","article-title":"Nitric oxide-donating carbonic anhydrase inhibitors for the treatment of open-angle glaucoma","volume":"19","author":"RM Steele","year":"2009","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1021\/jm8015987","article-title":"Virtual Screening Approach for the Identification of New Rac1 Inhibitors","volume":"52","author":"N Ferri","year":"2009","journal-title":"Journal of Medicinal Chemistry"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"14295","DOI":"10.1073\/pnas.97.26.14295","article-title":"Explaining the high mutation rates of cancer cells to drug and multidrug resistance by chromosome reassortments that are catalyzed by aneuploidy","volume":"97","author":"P Duesberg","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1126\/science.7038875","article-title":"Variation of Influenza-A, Influenza-B, and Influenza-C viruses","volume":"215","author":"P Palese","year":"1982","journal-title":"Science"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1128\/JVI.78.7.3722-3732.2004","article-title":"Positive selection detection in 40,000 human immunodeficiency virus (HIV) type 1 sequences automatically identifies drug resistance and positive fitness mutations in HIV protease and reverse transcriptase","volume":"78","author":"LM Chen","year":"2004","journal-title":"Journal of Virology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"W424","DOI":"10.1093\/nar\/gkq480","article-title":"SiMMap: a web server for inferring site-moiety map to recognize interaction preferences between protein pockets and compound moieties","volume":"38","author":"YF Chen","year":"2010","journal-title":"Nucleic Acids Research"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e32142","DOI":"10.1371\/journal.pone.0032142","article-title":"Core site-moiety maps reveal inhibitors and binding mechanisms of orthologous proteins by screening compound libraries","volume":"7","author":"KC Hsu","year":"2012","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/prot.20035","article-title":"GEMDOCK: a generic evolutionary method for molecular docking","volume":"55","author":"JM Yang","year":"2004","journal-title":"Proteins: Structure, Function, and Bioinformatics"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1023\/A:1011115820450","article-title":"DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases","volume":"15","author":"TJ Ewing","year":"2001","journal-title":"Journal of Computer-Aided Molecular Design"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8","article-title":"Evaluation of the FLEXX incremental construction algorithm for protein-ligand docking","volume":"37","author":"B Kramer","year":"1999","journal-title":"Proteins"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"G Jones","year":"1997","journal-title":"Journal of Molecular Biology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/prot.20387","article-title":"A pharmacophore-based evolutionary approach for screening selective estrogen receptor modulators","volume":"59","author":"JM Yang","year":"2005","journal-title":"Proteins-Structure Function and Bioinformatics"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1371\/journal.pone.0000428","article-title":"Combinatorial computational approaches to identify tetracycline derivatives as flavivirus inhibitors","volume":"2","author":"JM Yang","year":"2007","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jmb.2009.11.076","article-title":"The cAMP receptor-like protein CLP is a novel c-di-GMP receptor linking cell-cell signaling to virulence gene expression in Xanthomonas campestris","volume":"396","author":"KH Chin","year":"2010","journal-title":"Journal of Molecular Biology"},{"key":"ref32","first-page":"4268","article-title":"Rational design for crystallization of beta-lactoglobulin and vitamin D-3 complex: revealing a secondary binding site Crystal Growth &amp; Design","volume":"8","author":"MC Yang","year":"2008"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1021\/bi0205449","article-title":"Influenza neuraminidase inhibitors: Structure-based design of a novel inhibitor series","volume":"42","author":"V Stoll","year":"2003","journal-title":"Biochemistry"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1021\/jm049276y","article-title":"Structure-based characterization and optimization of novel hydrophobic binding interactions in a series of pyrrolidine influenza neuraminidase inhibitors","volume":"16","author":"CJ Maring","year":"2005","journal-title":"Journal of Medicinal Chemistry"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1021\/ja963036t","article-title":"Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: Design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity","volume":"119","author":"CU Kim","year":"1997","journal-title":"Journal of the American Chemical Society"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1021\/jm980162u","article-title":"Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors","volume":"41","author":"CU Kim","year":"1998","journal-title":"Journal of Medicinal Chemistry"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"10493","DOI":"10.1128\/JVI.00959-08","article-title":"Structural characterization of the 1918 influenza virus H1N1 neuraminidase","volume":"82","author":"X Xu","year":"2008","journal-title":"Journal of Virology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nature05003","article-title":"Structural biology: antiviral drugs fit for a purpose","volume":"443","author":"M Luo","year":"2006","journal-title":"Nature"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"11808","DOI":"10.1073\/pnas.94.22.11808","article-title":"Structural evidence for a second sialic acid binding site in avian influenza virus neuraminidases","volume":"94","author":"JN Varghese","year":"1997","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/nature06956","article-title":"Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants","volume":"453","author":"PJ Collins","year":"2008","journal-title":"Nature"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.antiviral.2008.10.006","article-title":"Aurintricarboxylic acid inhibits influenza virus neuraminidase","volume":"81","author":"HC Hung","year":"2009","journal-title":"Antiviral Research"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"8787","DOI":"10.1128\/JVI.00477-06","article-title":"Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses","volume":"80","author":"HL Yen","year":"2006","journal-title":"Journal of Virology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/pro.5560031007","article-title":"Influenza-Virus Neuraminidase - Structure, Antibodies, and Inhibitors","volume":"3","author":"PM Colman","year":"1994","journal-title":"Protein Science"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1186\/1471-2105-12-S1-S33","article-title":"iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis","volume":"12","author":"KC Hsu","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1128\/AAC.45.3.743-748.2001","article-title":"Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities","volume":"45","author":"DF Smee","year":"2001","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/jac\/dkp393","article-title":"BPR2-D2 targeting viral ribonucleoprotein complex-associated function inhibits oseltamivir-resistant influenza viruses","volume":"65","author":"SR Shih","year":"2010","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0042-6822(74)90080-4","article-title":"Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid","volume":"58","author":"P Meindl","year":"1974","journal-title":"Virology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e1002016","DOI":"10.1371\/journal.pcbi.1002016","article-title":"Exploring Off-Targets and Off-Systems for Adverse Drug Reactions via Chemical-Protein Interactome - Clozapine-Induced Agranulocytosis as a Case Study","volume":"7","author":"L Yang","year":"2011","journal-title":"PLoS Computational Biology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00894-011-1135-z","article-title":"In silico screening of epidermal growth factor receptor (EGFR) in the tyrosine kinase domain through a medicinal plant compound database","volume":"18","author":"O Sawatdichaikul","year":"2012","journal-title":"Journal of Molecular Modeling"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nrd1549","article-title":"Docking and scoring in virtual screening for drug discovery: Methods and applications","volume":"3","author":"DB Kitchen","year":"2004","journal-title":"Nature Reviews Drug Discovery"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1359-6446(02)02483-2","article-title":"Structure-based virtual screening: an overview","volume":"7","author":"PD Lyne","year":"2002","journal-title":"Drug Discovery Today"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrd2615","article-title":"Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening","volume":"7","author":"Y Tanrikulu","year":"2008","journal-title":"Nature Reviews Drug Discovery"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"W623","DOI":"10.1093\/nar\/gkp456","article-title":"PubChem: a public information system for analyzing bioactivities of small molecules","volume":"37","author":"YL Wang","year":"2009","journal-title":"Nucleic Acids Research"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/ci049714+","article-title":"ZINC - A free database of commercially available compounds for virtual screening","volume":"45","author":"JJ Irwin","year":"2005","journal-title":"Journal of Chemical Information and Modeling"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nchembio.479","article-title":"Accessing new chemical space for \u2018undruggable\u2019 targets","volume":"6","author":"S Dandapani","year":"2010","journal-title":"Nature Chemical Biology"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nature03193","article-title":"Navigating chemical space for biology and medicine","volume":"432","author":"C Lipinski","year":"2004","journal-title":"Nature"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJMc1003749","article-title":"Emergence of a Multidrug-Resistant Pandemic Influenza A (H1N1) Virus","volume":"363","author":"E van der Vries","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1200\/JCO.2003.10.038","article-title":"Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer","volume":"21","author":"M Fukuoka","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.clinthera.2005.10.014","article-title":"Erlotinib: Small-molecule targeted therapy in the treatment of non-small-cell lung cancer","volume":"27","author":"J Smith","year":"2005","journal-title":"Clinical Therapeutics"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1056\/NEJMoa044238","article-title":"EGFR mutation and resistance of non-small-cell lung cancer to gefitinib","volume":"352","author":"S Kobayashi","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1056\/NEJMp058291","article-title":"Oseltamivir resistance\u2013disabling our influenza defenses","volume":"353","author":"A Moscona","year":"2005","journal-title":"The New England Journal of Medicine"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1055\/s-0031-1283281","article-title":"Influenza Drug Resistance","volume":"32","author":"A Pizzorno","year":"2011","journal-title":"Seminars in Respiratory and Critical Care Medicine"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/bmj.2.5544.111-a","article-title":"Proflavine and acriflavine","volume":"2","author":"CH Browning","year":"1967","journal-title":"British Medical Journal"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1242\/jcs.02609","article-title":"Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication","volume":"118","author":"M Nunziante","year":"2005","journal-title":"Journal of Cell Science"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1475-2875-4-45","article-title":"Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841]","volume":"4","author":"PE Meissner","year":"2005","journal-title":"Malaria Journal"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-3156.2004.01356.x","article-title":"Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso","volume":"10","author":"G Mandi","year":"2005","journal-title":"Tropical Medicine & International Health"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature05114","article-title":"The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design","volume":"443","author":"RJ Russell","year":"2006","journal-title":"Nature"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/protein\/11.9.739","article-title":"Protein structure alignment by incremental combinatorial extension (CE) of the optimal path","volume":"11","author":"IN Shindyalov","year":"1998","journal-title":"Protein Engineering"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/bioinformatics\/bti770","article-title":"The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling","volume":"22","author":"K Arnold","year":"2006","journal-title":"Bioinformatics"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00124499","article-title":"Distributed automated docking of flexible ligands to proteins: parallel applications of AutoDock 2.4","volume":"10","author":"GM Morris","year":"1996","journal-title":"Journal of Computer-Aided Molecular Design"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1021\/ci050034w","article-title":"Consensus scoring criteria for improving enrichment in virtual screening","volume":"45","author":"J-M Yang","year":"2005","journal-title":"Journal of Chemical Information and Modeling"},{"key":"ref72","first-page":"5","article-title":"Reference viruses for seasonal and pandemic influenza vaccine preparation","volume":"1","author":"JM Wood","year":"2007","journal-title":"Influenza"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3727\/095535491820873191","article-title":"Use of an Aqueous Soluble Tetrazolium Formazan Assay for Cell-Growth Assays in Culture","volume":"3","author":"AH Cory","year":"1991","journal-title":"Cancer Communications"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1128\/JCM.02045-09","article-title":"Influenza Virus Inactivation for Studies of Antigenicity and Phenotypic Neuraminidase Inhibitor Resistance Profiling","volume":"48","author":"M Jonges","year":"2010","journal-title":"Journal of Clinical Microbiology"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0003-2697(79)90362-2","article-title":"Fluorometric Assay of Neuraminidase with a Sodium (4-Methylumbelliferyl-Alpha-D-N-Acetylneuraminate) Substrate","volume":"94","author":"M Potier","year":"1979","journal-title":"Analytical Biochemistry"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1021\/bi00010a003","article-title":"Structures of Aromatic Inhibitors of Influenza-Virus Neuraminidase","volume":"34","author":"MJ Jedrzejas","year":"1995","journal-title":"Biochemistry"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jmb.2005.11.061","article-title":"An epidemiologically significant epitope of a 1998 human influenza virus neuraminidase forms a highly hydrated interface in the NA-antibody complex","volume":"356","author":"L Venkatramani","year":"2006","journal-title":"Journal of Molecular Biology"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0314066","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0056704","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T21:54:10Z","timestamp":1588974850000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0056704"}},"subtitle":[],"editor":[{"given":"Yue","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,2,20]]},"references-count":77,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0056704","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,20]]}}}